DOJ Opens Landmark Antitrust Case Against Live Nation and Ticketmaster
Written by Emily J. Thompson, Senior Investment Analyst
Updated: 1 hour ago
0mins
Should l Buy LYV?
Source: seekingalpha
- Antitrust Case Opens: The DOJ's antitrust case against Live Nation and Ticketmaster commenced in federal court in Manhattan, with a jury set to determine if the company illegally monopolizes key aspects of the live music industry, potentially leading to a forced divestiture of Ticketmaster if the government prevails.
- Market Control Allegations: The lawsuit alleges that Live Nation's control over promotion, venues, and ticketing has created a self-reinforcing monopoly that harms fans, artists, and competitors, with practices that raise ticket prices and fees while limiting options for artists and venues, thereby suppressing competition.
- Witness List Revealed: The trial is expected to last five to six weeks, featuring a witness list that includes artists like Kid Rock and Ben Lovett from Mumford & Sons, as well as venue operators from places like Barclays Center and Live Nation CEO Michael Rapino, indicating the case's broad implications.
- Stock Performance: Despite the legal challenges, Live Nation's shares have risen 13.6% year-to-date, reflecting market confidence in its long-term growth potential, although the uncertainty surrounding the lawsuit may impact future performance.
Trade with 70% Backtested Accuracy
Stop guessing "Should I Buy LYV?" and start using high-conviction signals backed by rigorous historical data.
Sign up today to access powerful investing tools and make smarter, data-driven decisions.
Analyst Views on LYV
Wall Street analysts forecast LYV stock price to rise
14 Analyst Rating
14 Buy
0 Hold
0 Sell
Strong Buy
Current: 162.140
Low
164.00
Averages
175.86
High
190.00
Current: 162.140
Low
164.00
Averages
175.86
High
190.00
About LYV
Live Nation Entertainment, Inc. is a live entertainment company. The Company is a producer of live music concerts. Its segments include Concerts, Ticketing and Sponsorship & Advertising. The Concerts segment principally involves the global promotion of live music events in its owned or operated venues and in rented third-party venues, the operation and management of music venues, the production of music festivals across the world, the creation of associated content and the provision of management and other services to artists. The Ticketing segment is an agency business that sells tickets for events on behalf of its clients. The Sponsorship & Advertising segment employs a sales force that creates and maintains relationships with sponsors through a combination of strategic, international, national, and local opportunities that allow businesses to reach customers through its concert, festival, venue and ticketing assets, including advertising on its Websites.
About the author

Emily J. Thompson
Emily J. Thompson, a Chartered Financial Analyst (CFA) with 12 years in investment research, graduated with honors from the Wharton School. Specializing in industrial and technology stocks, she provides in-depth analysis for Intellectia’s earnings and market brief reports.
- Antitrust Case Opens: The DOJ's antitrust case against Live Nation and Ticketmaster commenced in federal court in Manhattan, with a jury set to determine if the company illegally monopolizes key aspects of the live music industry, potentially leading to a forced divestiture of Ticketmaster if the government prevails.
- Market Control Allegations: The lawsuit alleges that Live Nation's control over promotion, venues, and ticketing has created a self-reinforcing monopoly that harms fans, artists, and competitors, with practices that raise ticket prices and fees while limiting options for artists and venues, thereby suppressing competition.
- Witness List Revealed: The trial is expected to last five to six weeks, featuring a witness list that includes artists like Kid Rock and Ben Lovett from Mumford & Sons, as well as venue operators from places like Barclays Center and Live Nation CEO Michael Rapino, indicating the case's broad implications.
- Stock Performance: Despite the legal challenges, Live Nation's shares have risen 13.6% year-to-date, reflecting market confidence in its long-term growth potential, although the uncertainty surrounding the lawsuit may impact future performance.
See More
- Settlement Stalemate: Live Nation Entertainment (LYV) saw a 9% drop in after-hours trading due to multiple failed attempts to settle a federal antitrust lawsuit, indicating significant market uncertainty regarding the company's future.
- Trial Approaches: Jury selection is set for Monday, with the trial expected to last six weeks, making any settlement before then highly unlikely and exacerbating investor concerns about the company's legal challenges.
- Ongoing Negotiations: Despite the slow progress, Live Nation continues negotiations with the government, leaving open the possibility of a settlement during or after the trial, which could provide a glimmer of hope for the company's operations.
- Industry Implications: The lawsuit, filed in 2024, alleges that Live Nation deepened its power and influence across multiple sectors of the live events industry, and an unfavorable ruling could significantly impact its market position and financial performance.
See More
- Increased Bid: Paramount raised its offer for Warner Bros. Discovery from $30 to $31 per share, surpassing Netflix's $27.75 bid, demonstrating its competitive stance and acquisition ambitions in the media sector.
- Regulatory Approval Outlook: Analysts suggest that Paramount's acquisition is likely to face a smoother regulatory path compared to Netflix's proposal, although it still encounters a complex political and market landscape that could affect the deal's timing and conditions.
- Breakup Fee Arrangements: Paramount has committed to a $7 billion breakup fee in case of regulatory rejection, alongside covering the $2.8 billion fee Warner Bros. would owe Netflix, indicating its serious commitment to the transaction's success.
- Market Competition Impact: The merger between Paramount and Warner Bros. could lead to increased market concentration, with experts warning that this may reduce consumer choices and raise prices, particularly in the streaming and cable sectors, potentially triggering stricter regulatory scrutiny.
See More
- Core Stock Rating: Deutsche Bank reiterates its Buy rating on CoreWeave, lowering the price target from $140 to $125, indicating that the company faces uncertainties in its rapidly scaling financial model, which may impact investor confidence.
- Strong Airline Demand: TD Cowen upgrades Southwest Airlines from Hold to Buy with a target price of $66, anticipating strengthened airline demand in 2026, reflecting the potential for industry recovery.
- AI Software Leader: Rosenblatt initiates coverage of Palantir with a Buy rating and a $150 price target, believing the company holds a unique market position in AI with a sustainable growth trajectory, despite a 33% decline from its peak.
- Optimistic Financial Performance: Bank of America raises Dell's price target to $155, based on its broad product portfolio and AI-related growth potential, expecting higher margins in the coming years, although global economic slowdown poses some risks.
See More
- Shareholder Rights Investigation: Halper Sadeh LLC is investigating whether executives of Live Nation Entertainment, Inc. breached their fiduciary duties to shareholders, potentially impacting corporate governance and shareholder rights.
- Legal Relief Options: Long-term shareholders of Live Nation may seek corporate governance reforms, fund recovery, or court-approved financial awards, directly affecting their economic interests and rights.
- Importance of Participation: Shareholder involvement can enhance company policies and oversight mechanisms, thereby improving transparency and accountability, which ultimately helps to increase shareholder value and promote long-term corporate growth.
- Global Investor Representation: Halper Sadeh LLC represents investors worldwide, focusing on combating securities fraud and corporate misconduct, having successfully implemented corporate reforms and recovered millions for defrauded investors in the past.
See More
- Eli Lilly Upgrade: RBC has upgraded Eli Lilly to 'Outperform' with a price target of $1,250, citing its strong GLP-1 drug franchise and the launch of orforglipron, positioning the company favorably in the obesity treatment market, which is expected to drive revenue growth.
- Molson Coors Downgrade: Bank of America downgraded Molson Coors from 'Neutral' to 'Underperform' with a revised price target of $42, as the brewer's FY26 outlook was weaker than anticipated, indicating limited visibility into stabilizing volumes, which could dampen investor sentiment.
- Apple Price Target Increase: MoffettNathanson reiterated a 'Neutral' rating on Apple, raising its price target from $241 to $270, as positive earnings revisions following a strong December quarter make the valuation more attractive, potentially drawing increased investor interest.
- Amazon Buy Rating Maintained: Bank of America reiterated its 'Buy' rating on Amazon, suggesting that sentiment will improve as AWS revenues accelerate and new AI deals are signed, despite a 6% decline in Amazon shares since the Q4 earnings report, indicating a potential recovery ahead.
See More









